Community Oncology Alliance

 

2021 Community Oncology Conference
J

2021 Pancreatic Cancer Updates: Preoperative mFOLFIRINOX vs. Gem/nabP for Resectable Disease, Neoadjuvant XRT, Olaparib for Metastatic Disease

By 2021 Community Oncology Conference FEATURING Johanna Bendell
By 2021 Community Oncology Conference FEATURING Johanna Bendell
0 views
May 4, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

03:38
Lilly Medical Affairs

SERDS: Relevance and Role in Current & Future Treatments for HR+…

Feat. K. Jhaveri

Featured Video

04:43
Treatment Approach for Advanced Ovarian Cancer

The Role Of Folate Receptor Alpha In Ovarian Cancer

Feat. D. M. O'Malley
2021 Community Oncology Conference
12:52
2021 Community Oncology Conference

Opportunities & Challenges in TNBC: Navigating Immune CPI Effica…

Feat. J. O'Shaughnessy
15:12
2021 Community Oncology Conference

Advances in HER2+ BC: Overview of Current Data

Feat. J. O'Shaughnessy
08:18
2021 Community Oncology Conference

2021 Update on Frontline CLL: Comparing Treatment Outcomes With BTK …

Feat. J. Sharman
17:51
2021 Community Oncology Conference

2021 Update on Targeting Pathways in Frontline CLL: BTK Resistance, …

Feat. J. Sharman
13:21
2021 Community Oncology Conference

New Advances in KRASm NSCLC: Considering Sotorasib & Adagrasib E…

Feat. A. Spira
14:20
2021 Community Oncology Conference

2021 Update on EGFR Exon20ins in mNSCLC: Bispecific Antibody vs. TKI…

Feat. A. Spira
08:19
2021 Community Oncology Conference

2021 Data on HCC & mCRC: Atezo+Bev vs. Sorafenib in Unresectable…

Feat. J. Bendell
05:11
2021 Community Oncology Conference

2021 Biliary Tract Cancer Updates: Ivosidenib in Chemo-Refractory ID…

Feat. J. Bendell
05:17
2021 Community Oncology Conference

2021 Pancreatic Cancer Updates: Preoperative mFOLFIRINOX vs. Gem/nab…

Feat. J. Bendell
08:38
2021 Community Oncology Conference

2021 GE Cancer Updates: Nivo for Stage 2/3 EC/GEJC, Chemo+/-Pembro i…

Feat. J. Bendell
02:31
2021 Community Oncology Conference

Guide to Current Biomarker Testing for GI Cancers and Improvements i…

Feat. J. Bendell
39:14
2021 Community Oncology Conference

New Coding & Reimbursement Changes in 2021: Best Practices, Medi…

Feat. J. Blakely, R. Buell, B. Gamble, B. McAneny
40:03
2021 Community Oncology Conference

How to Maximize Practice Efficiencies and Reduce Costs: What Your Pr…

Feat. B. Gamble, M. Neubauer, T. O’Connell, A. Rahman
21:33
2021 Community Oncology Conference

Hospital Drug Pricing: Is Pricing Transparency Going to Change the C…

Feat. A. Gal
34:38
2021 Community Oncology Conference

How Employers Approach Cancer Care & Benefit Design: Strategies,…

Feat. R. Baird, Jr., B. Jackson, R. Opdycke, C. Shaffer
29:26
2021 Community Oncology Conference

Ensuring & Measuring Quality With a New Model for Cancer Care: P…

Feat. M. Diaz, B. Gamble, L. Wilfong
28:47
2021 Community Oncology Conference

Palliative Care in Oncology: Can It Improve QoL and Reduce the Use o…

Feat. M. Rezaie
12:27
2021 Community Oncology Conference

2021 IO & Gene Therapy Updates: Cancer Medicine and Vaccines in …

Feat. D. Spigel
13:31
2021 Community Oncology Conference

2021 Updates on Theranostics in Oncology: How Do Diagnostic & Th…

Feat. T. Abraham
37:09
2021 Community Oncology Conference

Biomarker Testing Updates: NGS vs. CGP, Who to Test, Predictive Biom…

Feat. M. Dietrich, B. Green, G. Oxnard, A. Sireci, B. Yoon
38:48
2021 Community Oncology Conference

Biosimilars in Cancer Care: Challenges & Opportunities From Rese…

Feat. E. Randolph Broun, S. Oskouei, K. Oubre, S. Parsad
52:02
2021 Community Oncology Conference

COVID-19 Pandemic Management: How Has Cancer Care Evolved and Innova…

Feat. L. Gordan, J. Perry, J. Pichoske